Financial Summary and Combined Balance Sheet
Published on in Breakthrough Report
A financial summary of revenue and expenditures for Children's Hospital of Philadelphia during the fiscal years of 2020, 2021 and 2022. (Fiscal year ends June 30.)
| Sources of Revenue | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Net Patient Service Revenue | $3,088,277,000 | $2,713,117,000 | $2,542,766,0001 |
| Other Operating Revenue | $264,185,000 | $318,277,000 | $198,193,000 |
| Contributions2 | $130,485,000 | $88,850,000 | $87,088,000 |
| Research | $320,651,000 | $303,972,000 | $249,875,000 |
| Total Sources of Revenue | $3,803,598,000 | $3,424,216,000 | $3,077,922,000 |
| Uses of Revenue | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Salaries, Wages and Employee Benefits | $2,021,345,000 | $1,747,728,000 | $1,634,891,000 |
| Supplies and Expenses | $818,222,000 | $721,130,000 | $675,388,000 |
| Depreciation | $207,333,000 | $196,933,000 | $192,189,000 |
| Interest | $12,727,000 | $19,299,000 | $17,446,000 |
| Research Expenses | $465,834,000 | $441,111,000 | $439,027,000 |
| Uncompensated Care | $8,112,000 | $15,353,000 | $9,765,0003 |
| Provisions for Programmatic Investments | $270,125,000 | $282,662,000 | $109,216,000 |
| Total Uses of Revenue | $3,803,698,000 | $3,424,216,000 | $3,077,922,000 |
Combined Balance Sheet
| Assets | FY 202 | FY 2021 | FY 2020 |
|---|---|---|---|
| Cash and Short-term Investments | $329,258,000 | $631,766,000 | $715,362,000 |
| Receivables | $875,130,000 | $627,744,000 | $381,490,000 |
| Other Current Assets | $313,368,000 | $232,274,000 | $232,058,000 |
| Total Current Assets | $1,517,756,000 | $1,491,784,000 | $1,328,910,000 |
| Investments | $4,241,152,000 | $4,632,292,000 | $3,240,019,000 |
| Property, Plant & Equipment (Net) | $3,442,114,000 | $3,100,508,000 | $2,818,825,000 |
| Other Assets | $297,282,000 | $315,328,000 | $112,773,000 |
| Total Investment Assets | $7,980,548,000 | $8,048,128,000 | $6,171,617,000 |
| Total Assets | $9,498,304,000 | $9,539,912,000 | $7,500,527,000 |
| Liabilities and Net Assets | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Current Portion of Long-term Debt | $22,373,000 | $21,119,000 | $19,581,000 |
| Accounts Payable and Accrued Expenses | $649,976,000 | $670,485,000 | $497,195,000 |
| Total Current Liabilities | $672,349,000 | $691,604,000 | $516,776,000 |
| Long-term Debt | $1,269,333,000 | $1,322,514,000 | $848,116,000 |
| Other Liabilities | $520,163,000 | $495,662,000 | $300,052,000 |
| Total Long-term Liabilities | $1,789,496,000 | $1,818,176,000 | $1,148,218,000 |
| Unrestricted Net Assets | $6,334,264,000 | $6,366,424,000 | $5,287,497,000 |
| Donor Restricted Net Assets | $702,195,000 | $663,708,000 | $548,086,000 |
| Total Net Assets | $7,036,459,000 | $7,030,132,000 | $5,835,583,000 |
| Total Liabilities and Net Assets | $9,498,304,000 | $9,539,912,000 | $7,500,577,000 |
(1) Net Patient Service Revenue for FY2020 includes $123,583,665 of Implicit Price Concessions (unpaid medical charges) which was previously included in Uncompensated Care.
(2) Includes unrestricted, temporarily restricted and permanently restricted contributions.
(3) $123,583,665 of Implicit Price Concessions (unpaid medical charges) for FY2020, which was included in Uncompensated Care in previous years, is now included in Net Patient Service Revenue.